Publications of Y. Genzel

Conference Paper (15)

2007
Conference Paper
Schulze-Horsel, J., Genzel, Y., & Reichl, U. (2007)Monitoring of Cell Physiology in Influenza Vaccine Production by Flow CytometryIn: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, 531–533doi: 10.1007/978-1-4020-5476-1_90.
2005
Conference Paper
Genzel, Y., Alt, R., & Reichl, U. (2005)Glutamine-free media for vaccine production processesIn: Animal Cell Technology meets Genomics: Proceedings ot the 18th ESACT Meeting, 767–770doi: 10.1007/1-4020-3103-3_159.
2003
Conference Paper
Reichl, U., Genzel, Y., Möhler, L., Sidorenko, Y., & Sann, H. (2003)Animal cell cultures for the production of viral vaccinesIn: GVC/DECHEMA Vortrags- und Diskussiontagung "Zellkulturen: vom biologischen System zum Produktionsprozess", 32–35.
2001
Conference Paper
Genzel, Y., Voges, L., & Reichl, U. (2001)Development of bioprocess concepts on vaccine production: influenza virus as an exampleIn: Animal cell technology: from target to market, 344–346.

Meeting Abstract (20)

2022
Meeting Abstract
Bürgin, T., Coronel, J., Fiddeke, K., Karlas, A., Sandig, V., Genzel, Y., Reichl, U., & Anderlei, T. (2022)Producing viruses in orbit: Current developments for orbital shaken viral vaccine manufacturingIn: Proceedings Vaccine Technology VIII, 54.
Meeting Abstract
Göbel, S., Dorn, M., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U. (2022)Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processesIn: Proceedings Vaccine Technology VIII, 60.
Meeting Abstract
Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U. (2022)Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionIn: Proceedings Single-Use Technologies V: Building the Future, 40.
Meeting Abstract
Offersgaard, A., Duarte Hernandez, C. R., Pihl, A. F., Costa, R., Prabhakar Venkatesan, N., Lin, X., Van Pham, L., Feng, S., Fahnøe, U., Høyer Scheel, T. K., Ramirez, S., Reichl, U., Bukh, J., Genzel, Y., & Gottwein, J. M. (2022)SARS-COV-2 production in a single-use scalable high cell density bioreactorIn: Proceedings Single-Use Technologies V: Building the Future, 29.
Meeting Abstract
Zinnecker, T. M., Behrendt, I., Lau, M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U. (2022)Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactorsIn: Proceedings Vaccine Technology VIII, 55.
2019
Meeting Abstract
Hein, M., Tapia, F., Genzel, Y., Kupke, S. Y., & Reichl, U. (2019)Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidatesIn: Integrated Continuous Biomanufacturing IV, 76.
Meeting Abstract
Marichal-Gallardo, P., Genzel, Y., Börner, K., Grimm, D., Wolff, M. W., & Reichl, U. (2019)A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccinesIn: Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92.
2018
Meeting Abstract
Bissinger, T., Reichl, U., Genzel, Y., Wu, Y., Liu, X., & Tan, W.-S. (2018)Highly efficient influenza virus production: A MDCK-based high-cell-density processIn: Vaccine Technology VII, 13.
Meeting Abstract
Coronel, J., Genzel, Y., Reichl, U., Behrendt, I., Buergin, T., Andereli, T., & Sandig, V. (2018)Orbital shaken bioreactor for influenza A virus production in high cell density cultivationsIn: Vaccine Technology VII, 40.
Meeting Abstract
Gränicher, G., Genzel, Y., Reichl, U., John, K., Sandig, V., & Karlas, A. (2018)A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine virusesIn: Vaccine Technology VII, 48.
Meeting Abstract
Marichal-Gallardo, P., Fortuna, A. R., Genzel, Y., Wolff, M. W., & Reichl, U. (2018)Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidatesIn: Vaccine Technology VII, 128.
Meeting Abstract
Nikolay, A., Genzel, Y., Schwamborn, K., Leon, A., & Reichl, U. (2018)Flavivirus production in perfusion processes using the EB66® cell lineIn: Vaccine Technology VII, 80.
Meeting Abstract
Wu, Y., Liu, X., Tan, W.-S., Bissinger, T., Genzel, Y., & Reichl, U. (2018)Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined mediumIn: Vaccine Technology VII, 5.
2017
Meeting Abstract
Tapia, F., Genzel, Y., Reichl, U., & Sandig, V. (2017)Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccinesIn: ECI Symposium Series.
2014
Meeting Abstract
Fernandes, P., Castro, R., Laske, T., Genzel, Y., Kremer, E., Alves, P., & Coroadinha, A. (2014)The impact of MDCK cell source on the production of influenza and canine adenovirusIn: New Biotechnology: Abstracts of the 16th European Congress on Biotechnology, S180doi: 10.1016/j.nbt.2014.05.907.
2011
Meeting Abstract
Janke, R., Genzel, Y., Wetzel, M., & Reichl, U. (2011)Effect of influenza virus infection on key metabolic enzyme activities in MDCK cellsIn: BMC Proceedings, P129doi: 10.1186/1753-6561-5-S8-P129.
Go to Editor View